Neoplasia (Tumor biology and immunology) Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	1988	Tumor growth and metastases in malignant disease. A review.	+	-	nl	J Med 19(3-4):179-91 (1988)
2	2009	Cell-derived microvesicles and cancer.	+	-	nl	Neth J Med 67(7):266-73 (2009)
3	1987	Cytotoxic cellular mediators of the immune response to neoplasia: a review.	+	-	nl	Yale J Biol Med 60(5):409-19 (1987)
4	2004	Pathophysiology of cerebral ischemia and brain trauma: similarities and differences.	+	-	nl	J Cereb Blood Flow Metab 24(2):133-50 (2004)
5	2006	Clinical implications of angiogenesis in cancers.	+	-	nl	Vasc Health Risk Manag 2(2):97-108 (2006)
6	2005	Pathophysiology of tumor neovascularization.	+	-	nl	Vasc Health Risk Manag 1(4):277-90 (2005)
7	2000	The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.	+	-	nl	Pharmacol Rev 52(2):179-206 (2000)
8	2008	AllergoOncology: the role of IgE-mediated allergy in cancer.	+	-	nl	Allergy 63(10):1255-66 (2008)
9	2009	Regulation of tumor immune surveillance and tumor immune subversion by tgf-Beta.	+	-	nl	Immune Netw 9(4):122-6 (2009)
10	2000	An overview of cancer immunotherapy.	+	-	nl	Immunol Cell Biol 78(3):179-95 (2000)
11	1987	Evasion of host defences by tumours.	+	-	nl	Immunol Cell Biol 65 ( Pt 4)(-):287-304 (1987)
12	1987	The immunogenicity of tumour cells.	+	-	nl	Immunol Cell Biol 65 ( Pt 4)(-):271-7 (1987)
13	2005	Dendritic cell dysfunction in cancer: a mechanism for immunosuppression.	+	-	nl	Immunol Cell Biol 83(5):451-61 (2005)
14	2008	Immunoglobulin expression and its biological significance in cancer cells.	+	-	nl	Cell Mol Immunol 5(5):319-24 (2008)
15	2007	The dual effects of interleukin-18 in tumor progression.	+	-	nl	Cell Mol Immunol 4(5):329-35 (2007)
16	2007	5T4 oncotrophoblast glycoprotein: janus molecule in life and a novel potential target against tumors.	+	-	nl	Cell Mol Immunol 4(2):99-104 (2007)
17	2007	Enhancing immune responses for cancer therapy.	+	-	nl	Cell Mol Immunol 4(3):173-84 (2007)
18	2005	New concepts in tumor antigens: their significance in future immunotherapies for tumors.	+	-	nl	Cell Mol Immunol 2(5):331-41 (2005)
19	2005	Cytokine and immuno-gene therapy for solid tumors.	+	-	nl	Cell Mol Immunol 2(2):81-91 (2005)
20	2004	A global approach to tumor immunology.	+	-	nl	Cell Mol Immunol 1(4):256-65 (2004)
21	2004	Forcing tumor cells to present their own tumor antigens to the immune system: a necessary design for an efficient tumor immunotherapy.	+	-	nl	Cell Mol Immunol 1(3):180-5 (2004)
22	2010	Premetastatic milieu explained by TLR4 agonist-mediated homeostatic inflammation.	+	-	nl	Cell Mol Immunol 7(2):94-9 (2010)
23	2004	The immunobiology of cancer immunosurveillance and immunoediting.	+	-	nl	Immunity 21(2):137-48 (2004)
24	1999	The makings of a tumor rejection antigen.	+	-	nl	Immunity 11(3):263-70 (1999)
25	1999	A new era for cancer immunotherapy based on the genes that encode cancer antigens.	+	-	nl	Immunity 10(3):281-7 (1999)
26	2007	Cancer immunoediting from immune surveillance to immune escape.	+	-	nl	Immunology 121(1):1-14 (2007)
27	2006	Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.	+	-	nl	Immunology 119(2):254-64 (2006)
28	2005	Intratumoral immunotherapy: using the tumour against itself.	+	-	nl	Immunology 114(1):11-22 (2005)
29	2001	Immunotherapy of melanoma.	+	-	nl	Immunology 104(1):1-7 (2001)
30	2008	Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms.	+	-	nl	J Immunol 180(4):2011-7 (2008)
31	2007	Unique human tumor antigens: immunobiology and use in clinical trials.	+	-	nl	J Immunol 178(4):1975-9 (2007)
32	2008	Immune-mediated dormancy: an equilibrium with cancer.	+	-	nl	J Leukoc Biol 84(4):988-93 (2008)
33	2006	Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.	+	-	nl	J Leukoc Biol 80(6):1183-96 (2006)
34	2006	Tumor growth or regression: powered by inflammation.	+	-	nl	J Leukoc Biol 80(4):685-90 (2006)
35	2006	Dual role of macrophages in tumor growth and angiogenesis.	+	-	nl	J Leukoc Biol 80(4):705-13 (2006)
36	2006	Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.	+	-	nl	J Leukoc Biol 80(4):691-6 (2006)
37	2006	Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response.	+	-	nl	J Leukoc Biol 79(4):652-62 (2006)
38	2004	Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.	+	-	nl	J Leukoc Biol 76(2):322-32 (2004)
39	2004	CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?	+	-	nl	J Leukoc Biol 76(2):307-13 (2004)
40	2002	Immune escape of tumors: apoptosis resistance and tumor counterattack.	+	-	nl	J Leukoc Biol 71(6):907-20 (2002)
41	2001	Leukocyte recruitment at sites of tumor: dissonant orchestration.	+	-	nl	J Leukoc Biol 70(2):171-84 (2001)
42	1999	Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells.	+	-	nl	J Leukoc Biol 66(5):718-22 (1999)
43	1998	Tumor-induced immune dysfunction: the macrophage connection.	+	-	nl	J Leukoc Biol 64(3):275-90 (1998)
44	1996	Human tumor antigens recognized by T lymphocytes: implications for cancer therapy.	+	-	nl	J Leukoc Biol 60(3):296-309 (1996)
45	1994	Cytokine networks in solid human tumors: regulation of angiogenesis.	+	-	nl	J Leukoc Biol 56(4):423-35 (1994)
46	1993	Involvement of inflammatory mediators in macrophage antitumor activity.	+	-	nl	J Leukoc Biol 54(6):613-26 (1993)
47	2009	Mast cells as regulators of adaptive immunity to tumours.	+	-	nl	Clin Exp Immunol 155(2):140-6 (2009)
48	1992	Why are transformed cells immortal? Is the process reversible?	+	-	nl	Am J Clin Nutr 55(6 Suppl):1215S-1221S (1992)
49	1981	Cancer and subversion of host defences.	+	-	nl	Aust J Exp Biol Med Sci 59(Pt 3):229-62 (1981)
50	2005	TGF beta signalling and its role in tumour pathogenesis.	+	-	nl	Acta Biochim Pol 52(2):329-37 (2005)
51	2009	Molecular pathways in tumor progression: from discovery to functional understanding.	+	-	nl	Mol Biosyst 5(9):902-8 (2009)
52	2002	The role of nitric oxide in cancer.	+	-	nl	Cell Res 12(5-6):311-20 (2002)
53	2001	Apoptosis in oncology.	+	-	nl	Cell Res 11(1):1-7 (2001)
54	2008	VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.	+	-	nl	Angiogenesis 11(3):257-67 (2008)
55	1999	Angiogenic switch and vascular stability in human Leydig cell tumours.	+	-	nl	Angiogenesis 3(3):231-40 (1999)
56	1998	Tumorigenicity depends on angiogenic potential of tumor cells: dominant role of vascular endothelial growth factor and/or fibroblast growth factors produced by tumor cells.	+	-	nl	Angiogenesis 2(1):57-66 (1998)
57	1998	The implications of angiogenesis on tumor invasiveness.	+	-	nl	Angiogenesis 2(1):21-3 (1998)
58	2008	Endocytosis and cancer: an 'insider' network with dangerous liaisons.	+	-	nl	Traffic 9(12):2011-21 (2008)
59	2008	Cancer metastasis as disrupted developmental phenotype.	+	-	nl	Curr Genomics 9(1):25-8 (2008)
60	1992	Functional role of glycosphingolipids in tumor progression.	+	-	nl	Tohoku J Exp Med 168(2):211-22 (1992)
61	2009	Endogenous and induced oxidative stress in multi-cellular tumour spheroids: implications for improving tumour therapy.	+	-	nl	Indian J Biochem Biophys 46(1):16-24 (2009)
62	2006	Tumour angiogenesis: the relevance to surgeons.	+	-	nl	Ann R Coll Surg Engl 88(6):525-9 (2006)
63	1977	Lymphocyte depression by cancer.	+	-	nl	Ann R Coll Surg Engl 59(3):222-30 (1977)
64	2006	Review article: immune suppression and colorectal cancer.	+	-	nl	Aliment Pharmacol Ther 24(8):1163-77 (2006)
65	2002	The angiogenic switch in solid tumors: clinical implications.	+	-	nl	Suppl Tumori 1(6):S9-11 (2002)
66	2009	Cell death pathways in response to antitumor therapy.	+	-	nl	Tumori 95(4):409-21 (2009)
67	1991	The exponential-Gompertzian tumor growth model: data from six tumor cell lines in vitro and in vivo. Estimate of the transition point from exponential to Gompertzian growth and potential clinical implications.	+	-	nl	Tumori 77(3):189-95 (1991)
68	1999	The role of the vascular phase in solid tumor growth: a historical review.	+	-	nl	Neoplasia 1(4):293-302 (1999)
69	1999	"...those left behind." Biology and oncology of invasive glioma cells.	+	-	nl	Neoplasia 1(3):208-19 (1999)
70	1999	Causes and effects of heterogeneous perfusion in tumors.	+	-	nl	Neoplasia 1(3):197-207 (1999)
71	2005	The role of serotonin in tumour growth (review).	+	-	nl	Oncol Rep 14(6):1593-7 (2005)
72	2007	Tumor-stroma interactions in pancreatic ductal adenocarcinoma.	+	-	nl	Mol Cancer Ther 6(4):1186-97 (2007)
73	2008	The effects of surgery on tumor growth: a century of investigations.	+	-	nl	Ann Oncol 19(11):1821-8 (2008)
74	2009	Why are tumour blood vessels abnormal and why is it important to know?	+	-	nl	Br J Cancer 100(6):865-9 (2009)
75	2008	Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness.	+	-	nl	Br J Cancer 98(12):1886-93 (2008)
76	2005	Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?	+	-	nl	Br J Cancer 92(2):209-11 (2005)
77	1974	Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.	+	-	nl	Br J Cancer 30(6):538-48 (1974)
78	1966	The growth rate of human tumours.	+	-	nl	Br J Cancer 20(1):74-86 (1966)
79	1988	The immunologic treatment of cancer.	+	-	nl	CA Cancer J Clin 38(2):68-94 (1988)
80	2007	The requirements for CTL-mediated rejection of cancer in humans: NKG2D and its role in the immune responsiveness of melanoma.	+	-	nl	Clin Cancer Res 13(24):7228-31 (2007)
81	2007	Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment.	+	-	nl	Clin Cancer Res 13(18 Pt 1):5256-61 (2007)
82	2007	Reversal of tumor-mediated immunosuppression.	+	-	nl	Clin Cancer Res 13(2 Pt 2):727s-732s (2007)
83	2005	The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.	+	-	nl	Clin Cancer Res 11(10):3601-3 (2005)
84	1996	How do lymphocytes kill tumor cells?	+	-	nl	Clin Cancer Res 2(5):785-9 (1996)
85	2007	Drug resistance and the solid tumor microenvironment.	+	-	nl	J Natl Cancer Inst 99(19):1441-54 (2007)
86	2000	Preventing cancer by disrupting progression of precancerous lesions.	+	-	nl	J Natl Cancer Inst 92(23):1868-9 (2000)
87	2008	The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.	+	-	nl	Oncologist 13(8):859-75 (2008)
88	2008	Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression.	+	-	nl	Cancer Sci 99(9):1720-5 (2008)
89	2008	Inflammation and cancer: role of nuclear factor-kappaB activation.	+	-	nl	Cancer Sci 99(5):836-42 (2008)
90	2008	Clinical applications of natural killer T cell-based immunotherapy for cancer.	+	-	nl	Cancer Sci 99(4):638-45 (2008)
91	2008	Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.	+	-	nl	Cancer Sci 99(3):479-85 (2008)
92	2007	Recklessness as a hallmark of aggressive cancer.	+	-	nl	Cancer Sci 98(11):1659-65 (2007)
93	2007	Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents.	+	-	nl	Cancer Sci 98(11):1643-51 (2007)
94	2007	Cancer stem cells.	+	-	nl	Cancer Sci 98(5):753-6 (2007)
95	2007	The immortalized cell lines with differentiation potentials: their establishment and possible application.	+	-	nl	Cancer Sci 98(3):275-83 (2007)
96	2006	Genetic instability in cancer cells by impaired cell cycle checkpoints.	+	-	nl	Cancer Sci 97(10):984-9 (2006)
97	2006	Natural killer T cell-mediated antitumor immune responses and their clinical applications.	+	-	nl	Cancer Sci 97(9):807-12 (2006)
98	2003	Tumor hypoxia: a target for selective cancer therapy.	+	-	nl	Cancer Sci 94(12):1021-8 (2003)
99	2003	Cell adhesion system and human cancer morphogenesis.	+	-	nl	Cancer Sci 94(7):575-81 (2003)
100	2008	Targeting the stroma by T cells to limit tumor growth.	+	-	nl	Cancer Res 68(23):9570-3 (2008)
101	2005	Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting.	+	-	nl	Cancer Res 65(19):8583-6 (2005)
102	1999	The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.	+	-	nl	Cancer Res 59(23):5863-70 (1999)
103	1998	The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.	+	-	nl	Cancer Res 58(7):1408-16 (1998)
104	1991	The inhibition of tumor growth by tumor mass.	+	-	nl	Cancer Res 51(1):2-4 (1991)
105	1989	Cancer as a disease of DNA organization and dynamic cell structure.	+	-	nl	Cancer Res 49(10):2525-32 (1989)
106	1988	Determinants of tumor blood flow: a review.	+	-	nl	Cancer Res 48(10):2641-58 (1988)
107	1988	Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation.	+	-	nl	Cancer Res 48(8):1996-2004 (1988)
108	1987	Biological and therapeutic potential of membrane lipid modification in tumors.	+	-	nl	Cancer Res 47(17):4529-37 (1987)
109	1987	Transport of molecules in the tumor interstitium: a review.	+	-	nl	Cancer Res 47(12):3039-51 (1987)
110	1987	The autoimmune nature of cancer.	+	-	nl	Cancer Res 47(4):927-32 (1987)
111	1975	Influence of a new virostatic compound on the induction of enzymes in rat liver.	+	-	nl	Arzneimittelforschung 25(9):1426-9 (1975) Kroger H
112	1987	Induction of transformed cells to terminal differentiation and the modulation of gene expression.	+	-	nl	Cancer Res 47(3):659-66 (1987)
113	1984	Perspectives on clonogenic tumor cells, stem cells, and oncogenes.	+	-	nl	Cancer Res 44(11):4909-18 (1984)
114	1984	Tumor heterogeneity.	+	-	nl	Cancer Res 44(6):2259-65 (1984)
115	1976	Cutaneous and muscular rasodilation in the canine hindlimb evoked by central stimulation.	+	-	nl	Circ Res 38(6):560-6 (1976) Lang WJ
116	1983	Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.	+	-	nl	Cancer Res 43(8):3466-92 (1983)
117	1978	Specificity of arrest, survival, and growth of selected metastatic variant cell lines.	+	-	nl	Cancer Res 38(11 Pt 2):4105-11 (1978)
118	1978	Chromosomal proteins in transformed and neoplastic cells: a review.	+	-	nl	Cancer Res 38(5):1181-201 (1978)
119	1977	A new concept of tissue and tumor cell proliferation.	+	-	nl	Cancer Res 37(11):3845-62 (1977)
120	1965	MECHANISM OF LIVER CATALASE DEPRESSION IN TUMOR-BEARING ANIMALS: A REVIEW.	+	-	nl	Cancer Res 25(-):34-45 (1965)
121	1963	SOME BIOCHEMICAL ESSENTIALS OF MALIGNANCY.	+	-	nl	Cancer Res 23(-):1474-82 (1963)
122	1963	SOME PROBLEMS BASIC TO CANCER RESEARCH WITHOUT PARTICULAR REFERENCE TO CHEMOTHERAPY.	+	-	nl	Cancer Res 23(-):1186-90 (1963)
123	1962	The surface properties of cancer cells: a review.	+	-	nl	Cancer Res 22(-):525-48 (1962)
124	1962	The cancer cell in vitro: a review.	+	-	nl	Cancer Res 22(-):431-40 (1962)
125	1960	Nucleic acid synthesis in the neoplastic cell and impact of nuclear changes on the biochemistry of tumor tissue: a review.	+	-	nl	Cancer Res 20(-):1121-48 (1960)
126	1960	Relationships of immunology to cancer: a review.	+	-	nl	Cancer Res 20(-):271-91 (1960)
127	1958	Nuclear proteins of tumors and other tissues: a review.	+	-	nl	Cancer Res 18(11):1241-56 (1958)
128	1958	Immunological enhancement of tumor homografts in mice: a review.	+	-	nl	Cancer Res 18(9):992-1003 (1958)
129	1958	Growth-promoting factors in tissues: a review.	+	-	nl	Cancer Res 18(9):981-91 (1958)
130	1958	Cellular metabolism and cancer: a review.	+	-	nl	Cancer Res 18(6):621-56 (1958)
131	1958	Electron microscopy of tumor cells and tumor viruses; a review.	+	-	nl	Cancer Res 18(5):491-509 (1958)
132	1957	Contributions of tissue culture studies to an understanding of the biology of cancer: a review.	+	-	nl	Cancer Res 17(10):929-41 (1957)
133	1957	Tumors characteristic for certain animal species; a review.	+	-	nl	Cancer Res 17(9):823-32 (1957)
134	1955	Microscopy. III. Cancer cytology and cytochemistry; a review.	+	-	nl	Cancer Res 15(9):557-72 (1955)
135	1954	Growth hormone and adrenocortical hormones in relation to experimental tumors; a review.	+	-	nl	Cancer Res 14(4):249-66 (1954)
136	1953	Conditioned and autonomous neoplasms: a review.	+	-	nl	Cancer Res 13(7:1):477-92 (1953)
137	1952	Some investigations on cell behavior under various conditions; a review.	+	-	nl	Cancer Res 12(12):847-60 (1952)
138	2008	Cadherins and cancer: how does cadherin dysfunction promote tumor progression?	+	-	nl	Oncogene 27(55):6920-9 (2008)
139	2005	Molecular theory of cancer.	+	-	nl	Cancer Biol Ther 4(6):621-7 (2005)
140	2005	The epithelial-mesenchymal transition (EMT) and colorectal cancer progression.	+	-	nl	Cancer Biol Ther 4(4):365-70 (2005)
141	2009	The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.	+	-	nl	Carcinogenesis 30(3):377-86 (2009)
142	2000	Genome changes and gene expression in human solid tumors.	+	-	nl	Carcinogenesis 21(3):443-52 (2000)
143	2004	Tumor stem cells.	+	-	nl	Pathol Oncol Res 10(2):69-73 (2004)
144	2000	Tumor sinuses- vascular channels.	+	-	nl	Pathol Oncol Res 6(2):83-6 (2000)
145	2006	The cancer stem cell: evidence for its origin as an injured autoreactive T cell.	+	-	nl	Mol Cancer 5(-):6 (2006)
146	2003	Molecular responses to hypoxia in tumor cells.	+	-	nl	Mol Cancer 2(-):23 (2003)
147	2006	Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment.	+	-	nl	Mol Cancer Res 4(2):61-70 (2006)
148	2009	Stroma -- regulator of cancer cell progression.	+	-	nl	Exp Oncol 31(3):126 (2009)
149	2009	Tumor hypoxia and malignant progression.	+	-	nl	Exp Oncol 31(2):80-6 (2009)
150	2002	Principles of tumor immunosurveillance and implications for immunotherapy.	+	-	nl	Cancer Gene Ther 9(12):1043-55 (2002)
151	2004	Crosstalk between angiogenesis and lymphangiogenesis in tumor progression.	+	-	nl	Leukemia 18(6):1054-8 (2004)
152	2010	Dual role of complement in tumour growth and metastasis (Review).	+	-	nl	Int J Mol Med 25(3):307-13 (2010)
153	1998	Regulation of cell adhesion, a central mechanism in the anticancer action of essential fatty acids (review).	+	-	nl	Int J Mol Med 1(3):621-5 (1998)
154	2009	Mitochondrial DNA instability and metabolic shift in human cancers.	+	-	nl	Int J Mol Sci 10(2):674-701 (2009)
155	2011	The essential role of evasion from cell death in cancer.	+	-	nl	Adv Cancer Res 111(-):39-96 (2011)
156	2008	The role of NKT cells in tumor immunity.	+	-	nl	Adv Cancer Res 101(-):277-348 (2008)
157	2009	Interaction of indoleamine-2,3-dioxyagnase and CD4+CD25+ regulatory T cells in tumor immune escape.	+	-	nl	Ai Zheng 28(2):184-7 (2009)
158	2002	Tumors and the danger model.	+	-	nl	Acta Biochim Pol 49(2):295-302 (2002)
159	2010	Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer.	+	-	nl	Adv Enzyme Regul 50(1):160-7 (2010)
160	2011	Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.	+	-	nl	Am J Cancer Res 1(6):787-805 (2011)
161	2011	Cancer associated fibroblasts: the dark side of the coin.	+	-	nl	Am J Cancer Res 1(4):482-97 (2011)
162	2010	Cancer stem cells.	+	-	nl	Ann Oncol 21 Suppl 7(-):vii93-4 (2010)
163	2002	Tumor microenvironment and the response to anticancer therapy.	+	-	nl	Cancer Biol Ther 1(5):453-8 (2002)
164	2008	Trophinin: what embryo implantation teaches us about human cancer.	+	-	nl	Cancer Biol Ther 7(8):1165 (2008)
165	2003	The complexity of tumor vascularity.	+	-	nl	Cancer Biol Ther 2(3):257-8 (2003) Sood AK
166	2005	Achieving hypoxia-inducible gene expression in tumors.	+	-	nl	Cancer Biol Ther 4(4):359-64 (2005)
167	2009	Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.	+	-	nl	Cancer Biol Ther 8(19):1791-7 (2009)
168	2010	Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors.	+	-	nl	Am J Pathol 176(4):1564-76 (2010)
169	2007	Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.	+	-	nl	Am J Physiol Cell Physiol 292(3):C987-95 (2007)
170	2010	The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies.	+	-	nl	Biochim Biophys Acta 1797(6-7):1225-30 (2010)
171	2010	Tumor heterogeneity: causes and consequences.	+	-	nl	Biochim Biophys Acta 1805(1):105-17 (2010)
172	2010	Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.	+	-	nl	Biochim Biophys Acta 1803(1):103-20 (2010)
173	2010	Metabolic genes in cancer: their roles in tumor progression and clinical implications.	+	-	nl	Biochim Biophys Acta 1805(2):141-52 (2010)
174	2009	Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.	+	-	nl	Biochim Biophys Acta 1791(9):949-55 (2009)
175	2009	Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.	+	-	nl	Biochim Biophys Acta 1796(1):19-26 (2009)
176	2009	A systems biology view of cancer.	+	-	nl	Biochim Biophys Acta 1796(2):129-39 (2009)
177	2008	P53, cyclin-dependent kinase and abnormal amplification of centrosomes.	+	-	nl	Biochim Biophys Acta 1786(1):15-23 (2008)
178	2008	Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.	+	-	nl	Biochim Biophys Acta 1785(2):85-95 (2008)
179	2010	The perivascular niche microenvironment in brain tumor progression.	+	-	nl	Cell Cycle 9(15):3012-21 (2010)
180	2006	Negative feedbacks in normal cell growth and their suppression in tumorigenesis.	+	-	nl	Cell Cycle 5(6):571-2 (2006)
181	2006	Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta.	+	-	nl	Cell Cycle 5(9):953-7 (2006)
182	2006	Check, double check: the G2 barrier to cancer.	+	-	nl	Cell Cycle 5(8):831-6 (2006)
183	2006	Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions.	+	-	nl	Cell Cycle 5(7):691-5 (2006)
184	2011	Could TCTP contribute to Armin Braun's paradigm of tumor reversion in plants?	+	-	nl	Cell Cycle 10(1):1 (2011)
185	2010	The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox.	+	-	nl	Cell Cycle 9(21):4297-306 (2010)
186	2003	Redirection of oncoproteins to kill cancer cells.	+	-	nl	Cell Cycle 2(6):531-3 (2003)
187	2003	Cell immortality and hallmarks of cancer.	+	-	nl	Cell Cycle 2(4):296-9 (2003)
188	2010	Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes.	+	-	nl	Cell Cycle 9(2):260-8 (2010)
189	2007	What makes tumors multidrug resistant?	+	-	nl	Cell Cycle 6(22):2782-7 (2007)
190	2007	HIF-1-regulated glucose metabolism: a key to apoptosis resistance?	+	-	nl	Cell Cycle 6(7):790-2 (2007)
191	2011	Human umbilical cord blood-derived mesenchymal stem cells and their effect on gliomas.	+	-	nl	Neurol India 59(2):226-8 (2011)
192	2010	Lymphangiogenesis: a new player in cancer progression.	+	-	nl	World J Gastroenterol 16(32):4003-12 (2010)
193	2009	Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.	+	-	nl	Mayo Clin Proc 84(11):985-1000 (2009)
194	2010	Protection from cancer in kidney transplant patients by gammadelta T cells: role of CMV infection?	+	-	nl	J Am Soc Nephrol 21(1):11-3 (2010) Soderberg-Naucler C
195	2011	Natural killer cells in human cancer: from biological functions to clinical applications.	+	-	nl	J Biomed Biotechnol 2011(-):676198 (2011)
196	2010	Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.	+	-	nl	J Biomed Biotechnol 2010(-):- (2010)
197	2010	Perforin deficiency and susceptibility to cancer.	+	-	nl	Cell Death Differ 17(4):607-15 (2010)
198	2008	Tumor stress, cell death and the ensuing immune response.	+	-	nl	Cell Death Differ 15(1):21-8 (2008)
199	2008	The 'kiss of death' by dendritic cells to cancer cells.	+	-	nl	Cell Death Differ 15(1):58-69 (2008)
200	2008	Interactions of tumor cells with dendritic cells: balancing immunity and tolerance.	+	-	nl	Cell Death Differ 15(1):39-50 (2008)
201	2008	T-cell death and cancer immune tolerance.	+	-	nl	Cell Death Differ 15(1):70-9 (2008)
202	2009	Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.	+	-	nl	J Cell Sci 122(Pt 11):1723-36 (2009)
203	2008	Cadherin switching.	+	-	nl	J Cell Sci 121(Pt 6):727-35 (2008)
204	2010	Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma.	+	-	nl	ScientificWorldJournal 10(-):1947-57 (2010)
205	2009	The role of the calcium-sensing receptor in the development and progression of cancer.	+	-	nl	Endocr Rev 30(2):178-95 (2009)
206	2009	Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.	+	-	nl	Blood 113(14):3139-46 (2009)
207	2006	Regulatory T cells in cancer.	+	-	nl	Blood 108(3):804-11 (2006)
208	2011	Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment.	+	-	nl	J Pharmacol Sci 115(4):446-52 (2011)
209	2011	Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery:hypoxia-inducible factor-1 (HIF-1)-active cells as a target for cancer therapy.	+	-	nl	J Pharmacol Sci 115(4):440-5 (2011)
210	2010	Modeling stromal-epithelial interactions in disease progression.	+	-	nl	Discov Med 9(49):504-11 (2010)
211	2011	Cell lineage specification in tumor progression and metastasis.	+	-	nl	Discov Med 12(65):329-40 (2011)
212	2007	Mechanisms to control rereplication and implications for cancer.	+	-	nl	Curr Opin Cell Biol 19(6):663-71 (2007)
213	2008	The anticancer immune response: indispensable for therapeutic success?	+	-	nl	J Clin Invest 118(6):1991-2001 (2008)
214	2010	Cancer genomics identifies determinants of tumor biology.	+	-	nl	Genome Biol 11(5):211 (2010)
215	2007	Intranuclear changes in cancer cells.	+	-	nl	Genome Biol 8(8):312 (2007)
216	2010	Cancer associated fibroblasts in cancer pathogenesis.	+	-	nl	Semin Cell Dev Biol 21(1):33-9 (2010)
217	2010	Involvement of stromal p53 in tumor-stroma interactions.	+	-	nl	Semin Cell Dev Biol 21(1):47-54 (2010)
218	2010	Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.	+	-	nl	Semin Cell Dev Biol 21(1):66-71 (2010)
219	2010	Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.	+	-	nl	Semin Cell Dev Biol 21(1):19-25 (2010)
220	2007	Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.	+	-	nl	EMBO Rep 8(11):1024-30 (2007)
221	2009	IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.	+	-	nl	EMBO Rep 10(12):1314-9 (2009)
222	2007	Cancer stem cell: target for anti-cancer therapy.	+	-	nl	FASEB J 21(14):3777-85 (2007)
223	2006	Autophagy signaling and the cogwheels of cancer.	+	-	nl	Autophagy 2(2):67-73 (2006)
224	2010	Guidance molecules in lung cancer.	+	-	nl	Cell Adh Migr 4(1):130-45 (2010)
225	2010	Integrin signaling and lung cancer.	+	-	nl	Cell Adh Migr 4(1):124-9 (2010)
226	2007	Viewing malignant melanoma cells as macrophage-tumor hybrids.	+	-	nl	Cell Adh Migr 1(1):2-6 (2007)
227	2009	The role of focal adhesion kinase in tumor initiation and progression.	+	-	nl	Cell Adh Migr 3(4):347-50 (2009)
228	2010	Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators.	+	-	nl	Curr Opin Genet Dev 20(1):41-50 (2010)
229	2008	Application of activity-based probes to the study of enzymes involved in cancer progression.	+	-	nl	Curr Opin Genet Dev 18(1):97-106 (2008)
230	2008	Microenvironmental regulation of cancer development.	+	-	nl	Curr Opin Genet Dev 18(1):27-34 (2008)
231	2003	Natural T cell immunity against cancer.	+	-	nl	Clin Cancer Res 9(12):4296-303 (2003)
232	2010	Nuclear factor-kappaB and tumor-associated macrophages.	+	-	nl	Clin Cancer Res 16(3):784-9 (2010)
233	2007	PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.	+	-	nl	Clin Cancer Res 13(6):1757-61 (2007)
234	2008	Capitalizing on the immunogenicity of dying tumor cells.	+	-	nl	Clin Cancer Res 14(6):1603-8 (2008)
235	2008	The immunogenicity of the hTERT540-548 peptide in cancer.	+	-	nl	Clin Cancer Res 14(1):4-7 (2008)
236	2004	The role of hypoxia-induced factors in tumor progression.	+	-	nl	Oncologist 9 Suppl 5(-):10-7 (2004)
237	2008	Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis.	+	-	nl	Oncologist 13 Suppl 3(-):21-6 (2008)
238	2010	Tumor progression by immune evasion in melanoma: role of the programmed cell death-1/programmed cell death-1 ligand 1 interaction.	+	-	nl	Cancer 116(7):1623-5 (2010) Kashani-Sabet M
239	2010	CD73: a novel target for cancer immunotherapy.	+	-	nl	Cancer Res 70(16):6407-11 (2010)
240	2006	Distinct role of macrophages in different tumor microenvironments.	+	-	nl	Cancer Res 66(2):605-12 (2006)
241	2006	Eighteenth annual pezcoller symposium: tumor microenvironment and heterotypic interactions.	+	-	nl	Cancer Res 66(24):11550-3 (2006)
242	2002	What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors?	+	-	nl	Cancer Res 62(7):1931-4 (2002)
243	2002	Significance of blood vessel leakiness in cancer.	+	-	nl	Cancer Res 62(18):5381-5 (2002)
244	2010	Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA.	+	-	nl	Cancer Res 70(22):8977-80 (2010)
245	2010	Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy.	+	-	nl	Cancer Res 70(6):2141-5 (2010)
246	2007	Tumor angiogenesis: cause or consequence of cancer?	+	-	nl	Cancer Res 67(15):7059-61 (2007)
247	2009	Tumor immunology: new perspectives.	+	-	nl	Cancer Res 69(18):7157-9 (2009)
248	2008	Yin-yang activities and vicious cycles in the tumor microenvironment.	+	-	nl	Cancer Res 68(1):9-13 (2008)
249	2002	Intra-tumoural microvessel density in human solid tumours.	+	-	nl	Br J Cancer 86(10):1566-77 (2002)
250	2011	Patterns in the occurrence and development of tumors.	+	-	nl	Chin Med J (Engl) 124(7):1097-104 (2011)
251	2011	Cancer cells can be tricked into self-destructing.	+	-	nl	Future Oncol 7(3):323-5 (2011)
252	2010	Energy restriction as an antitumor target.	+	-	nl	Future Oncol 6(11):1675-9 (2010)
253	2009	The TGF-beta paradox in human cancer: an update.	+	-	nl	Future Oncol 5(2):259-71 (2009)
254	2007	Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3).	+	-	nl	JOP 8(6):697-703 (2007)
255	2007	Insights into the cancer stem cell model of glioma tumorigenesis.	+	-	nl	Ann Acad Med Singapore 36(5):352-7 (2007)
256	2010	Targeting inhibitory pathways in cancer immunotherapy.	+	-	nl	Curr Opin Immunol 22(3):385-90 (2010)
257	2010	Immunity to stemness genes in human cancer.	+	-	nl	Curr Opin Immunol 22(2):245-50 (2010)
258	2010	Adoptive T cell therapy of cancer.	+	-	nl	Curr Opin Immunol 22(2):251-7 (2010)
259	2009	Adoptive immunotherapy of cancer using CD4(+) T cells.	+	-	nl	Curr Opin Immunol 21(2):200-8 (2009)
260	2009	Adoptive transfer of virus-specific and tumor-specific T cell immunity.	+	-	nl	Curr Opin Immunol 21(2):224-32 (2009)
261	2009	Adoptive T cell therapy of cancer.	+	-	nl	Curr Opin Immunol 21(2):187-9 (2009)
262	2008	Peptide epitope identification for tumor-reactive CD4 T cells.	+	-	nl	Curr Opin Immunol 20(2):221-7 (2008)
263	2008	Role of Stat3 in suppressing anti-tumor immunity.	+	-	nl	Curr Opin Immunol 20(2):228-33 (2008)
264	2010	Editorial: PGE2-producing MDSC: a role in tumor progression?	+	-	nl	J Leukoc Biol 88(5):827-9 (2010) Serafini P
265	2010	Genetic redirection of T cells for cancer therapy.	+	-	nl	J Leukoc Biol 87(5):791-803 (2010)
266	2003	Rational approaches to human cancer immunotherapy.	+	-	nl	J Leukoc Biol 73(1):3-29 (2003)
267	2009	Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.	+	-	nl	J Leukoc Biol 86(5):1065-73 (2009)
268	2009	Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages.	+	-	nl	J Leukoc Biol 86(5):1105-9 (2009)
269	2008	Polarized immune responses differentially regulate cancer development.	+	-	nl	Immunol Rev 222(-):145-54 (2008)
270	2008	Antigen-specific immunotherapy of cervical and ovarian cancer.	+	-	nl	Immunol Rev 222(-):43-69 (2008)
271	2006	CD8+ T-cell memory in tumor immunology and immunotherapy.	+	-	nl	Immunol Rev 211(-):214-24 (2006)
272	2011	PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.	+	-	nl	Clin Dev Immunol 2011(-):947858 (2011)
273	2011	The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance.	+	-	nl	Clin Dev Immunol 2011(-):430394 (2011)
274	2010	Dendritic cell-based immunotherapy for prostate cancer.	+	-	nl	Clin Dev Immunol 2010(-):517493 (2010)
275	2010	B7-h3 and its role in antitumor immunity.	+	-	nl	Clin Dev Immunol 2010(-):683875 (2010)
276	2010	DNA vaccination: using the patient's immune system to overcome cancer.	+	-	nl	Clin Dev Immunol 2010(-):169484 (2010)
277	2010	T cell-tumor interaction directs the development of immunotherapies in head and neck cancer.	+	-	nl	Clin Dev Immunol 2010(-):236378 (2010)
278	2010	Prognostic and diagnostic value of spontaneous tumor-related antibodies.	+	-	nl	Clin Dev Immunol 2010(-):721531 (2010)
279	2010	Focus on adoptive T cell transfer trials in melanoma.	+	-	nl	Clin Dev Immunol 2010(-):260267 (2010)
280	2010	Theoretical modeling techniques and their impact on tumor immunology.	+	-	nl	Clin Dev Immunol 2010(-):271794 (2010)
281	2010	The initial immune reaction to a new tumor antigen is always stimulatory and probably necessary for the tumor's growth.	+	-	nl	Clin Dev Immunol 2010(-):- (2010)
282	2010	Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27.	+	-	nl	Clin Dev Immunol 2010(-):- (2010)
283	2010	Vaccines and immunotherapeutics for the treatment of malignant disease.	+	-	nl	Clin Dev Immunol 2010(-):697158 (2010)
284	2010	Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.	+	-	nl	Clin Dev Immunol 2010(-):239083 (2010)
285	2010	Overview of cellular immunotherapy for patients with glioblastoma.	+	-	nl	Clin Dev Immunol 2010(-):- (2010)
286	2010	NGcGM3 ganglioside: a privileged target for cancer vaccines.	+	-	nl	Clin Dev Immunol 2010(-):814397 (2010)
287	2010	Regulation of tumor immunity by tumor/dendritic cell fusions.	+	-	nl	Clin Dev Immunol 2010(-):516768 (2010)
288	2010	Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity.	+	-	nl	Clin Dev Immunol 2010(-):139304 (2010)
289	2009	Cancer vaccine by fusions of dendritic and cancer cells.	+	-	nl	Clin Dev Immunol 2009(-):657369 (2009)
290	2010	Tumor antigen-dependent and tumor antigen-independent activation of antitumor activity in T cells by a bispecific antibody-modified tumor vaccine.	+	-	nl	Clin Dev Immunol 2010(-):423781 (2010)
291	2010	Immunotherapy of brain cancers: the past, the present, and future directions.	+	-	nl	Clin Dev Immunol 2010(-):296453 (2010)
292	2010	Immune suppression in head and neck cancers: a review.	+	-	nl	Clin Dev Immunol 2010(-):701657 (2010)
293	2010	Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art.	+	-	nl	Semin Immunol 22(3):105-12 (2010)
294	2010	Whole tumor antigen vaccines.	+	-	nl	Semin Immunol 22(3):132-43 (2010)
295	2010	Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.	+	-	nl	Semin Immunol 22(3):173-82 (2010)
296	2011	Epigenetic regulation of cancer-associated genes in ovarian cancer.	+	-	nl	Int J Mol Sci 12(2):983-1008 (2011)
297	2011	New Aspects of Mitochondrial Uncoupling Proteins (UCPs) and Their Roles in Tumorigenesis.	+	-	nl	Int J Mol Sci 12(8):5285-93 (2011)
298	2010	Large non-coding RNAs: missing links in cancer?	+	-	nl	Hum Mol Genet 19(R2):R152-61 (2010)
299	2010	Analysis of next-generation genomic data in cancer: accomplishments and challenges.	+	-	nl	Hum Mol Genet 19(R2):R188-96 (2010)
300	2007	Epigenetic gene silencing in cancer: the DNA hypermethylome.	+	-	nl	Hum Mol Genet 16 Spec No 1(-):R50-9 (2007)
301	2009	Cancer genome sequencing: a review.	+	-	nl	Hum Mol Genet 18(R2):R163-8 (2009)
302	2011	Making sense of cancer genomic data.	+	-	nl	Genes Dev 25(6):534-55 (2011)
303	2011	The dynamic nature of autophagy in cancer.	+	-	nl	Genes Dev 25(19):1999-2010 (2011)
304	2007	The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer.	+	-	nl	Genes Dev 21(18):2258-70 (2007)
305	2009	Tumor suppressors and cell metabolism: a recipe for cancer growth.	+	-	nl	Genes Dev 23(5):537-48 (2009)
306	2008	Migratory neighbors and distant invaders: tumor-associated niche cells.	+	-	nl	Genes Dev 22(5):559-74 (2008)
307	2010	Cancer associated fibroblasts (CAFs) in tumor microenvironment.	+	-	nl	Front Biosci 15(-):166-79 (2010)
308	2007	Targeting the tumor microenvironment.	+	-	nl	Front Biosci 12(-):3468-74 (2007)
309	2009	The inflammatory network: bridging senescent stroma and epithelial tumorigenesis.	+	-	nl	Front Biosci 14(-):4044-57 (2009)
310	2009	Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges.	+	-	nl	Front Biosci 14(-):796-807 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.